Prevalence and impact of diabetes and prediabetes on presentation and complications of primary hyperaldosteronism at diagnosis

Table 4 Type and number Pattern of complications in the study population, n (%)

Comorbidities	Non-diabetes (n = 30)	Prediabetes (n = 19)	T2DM (n = 29)	P value
Mean number of complications (mean ± SD)	1.4 ± 0.97	1.5 ± 0.8	1.7 ± 0.8	NS
LVH	23 (76.7)	17 (89.5)	26 (89.7)	NS
CKD 3	17 (56.7)	12 (63.2)	17 (58.7)	NS
CAD	3 (10)	4 (21)	8 (27.6)	NS
CVA	1 (3.3)	3 (15.8)	1 (3.4)	NS
No. of complications
0	3 (10)	3 (15.8)	3 (10.3)	NS
1	2 (6.7)	2 (10.5)	4 (13.8)
2	7 (23.3)	8 (42.1)	12 (41.4)
3	18 (60)	6 (31.6)	9 (31)
4	0 (0)	0 (0)	1 (3.4)

NS: Non-significant, P ≥ 0.05; P < 0.05: Statistically significant; T2DM: Type 2 diabetes mellitus; LVH: Left ventricular hypertrophy; CKD: Chronic kidney disease; CAD: Coronary artery disease; CVA: Cerebrovascular accident; HTN: Hypertension; OSA: Obstructive sleep apnea.